Sunstone Metals (ASX:STM) is an ASX-listed mineral exploration company with two world-class gold and copper assets in Ecuador. Sunstone’s two porphyry projects are the Bramaderos Gold-Copper Project and the El Palmar Gold-Copper Project.
Copyright 2024 – Finance News Network
18 Dec 2019 - Prospect Resources Limited (ASX:PSC) Managing Director, Sam Hosack, provides an update on the company's Arcadia lithium project in Zimbabwe, including advanced negotiations with a number of African and international banks on funding.
30 Mar 2022 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses the company's LAG-3-related therapies, outlining future plans and expected data readouts for Immutep's lead drug, eftilagimod alpha.
25 Sep 2023 - Wally Graham of Resources Roadhouse at the New World Metals Conference, speaking with Dean Tuck, Managing Director of Dreadnought Resources (ASX:DRE).
16 Apr 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook talks about the growing demand for digital payments and the opportunities this presents for the company.
10 Jul 2023 - INOVIQ Limited (ASX:IIQ) CEO Dr Leearne Hinch discusses recent news, including excellent sensitivity and specificity results for the company's SubB2M breast cancer test.
04 May 2023 - Phil Hoskins, Managing Director of Evolution Energy Minerals (ASX:EV1), discusses EV1's Tanzanian Graphite project, the recent updated DFS and the formal signing of framework agreement with the Tanzanian Government.
18 Oct 2019 - Calima Energy Limited (ASX:CE1) Managing Director, Alan Stein, talks about the company's strategy, recent capital raising, and results from the drill program at its Montney project.
11 Sep 2023 - QANTM Intellectual Property Limited (ASX:QIP) CEO and Managing Director Craig Dower discusses drivers of revenue, competitors and market share, and the company's ambitions to expand into Asia.
27 May 2022 - TerraCom Limited (ASX:TER) Executive Chairman Craig Ransley discusses drivers behind the company's performance and share price over the previous year.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.